High-risk TP53 mutations predict poor primary treatment response of patients with head and neck squamous cell carcinoma

2023

Vito Carlo Alberto Caponio, Khrystyna Zhurakivska, Marco Mascitti, Lucrezia Togni, Francesca Spirito, Nicola Cirillo, Lorenzo Lo Muzio, Giuseppe Troiano